N2-[(2R)-4-(Hydroxyamino)-2-(2-naphthalenylmethyl)-1,4-dioxobutyl]-L-arginyl-L-tryptophyl-L-α-glutamine is a substrate-selective peptide hydroxamate inhibitor of insulin-degrading enzyme.